"Federal regulators are working on a stronger label for a widely used diabetes drug marketed by Amylin Pharmaceuticals Inc. and Eli Lilly & Co. after deaths were reported with the medication despite earlier government warnings.Hey, not bad.
The Food and Drug Administration said Monday it has received six new reports of patients developing a dangerous form of pancreatitis while taking Byetta. Two of the patients died and four were recovering...
the injectable drug...was launched in June 2005."
Just over 3 years and they still haven't figured out how to label it properly.
But they are "working on" it.
Not to worry. It is only people who are dying. It's not as if Eli Lilly or Amylin, who "jointly developed and manufactured" the drug are dying.
They are only taking a small market hit
"Shares of Amylin Pharmaceuticals fell $4.45, or 13 percent, to $29.76 Monday, while Indianapolis-based Eli Lilly dipped 73 cents to $48.05."Whew.
What will they find out about the IMHO malpractice known as diet drugs?
Rest assured.
Time will tell.
By speaking for the dead and harmed.
Better to lose weight the right way.
No comments:
Post a Comment